Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 May 30;9(5):e1289.
doi: 10.7759/cureus.1289.

Proposal for a Pharmacogenetic Decision Algorithm

Saeed K Alzghari  1 , Lori Blakeney  1 , Kerry Anne Rambaran  2
Affiliations
Editorial

Proposal for a Pharmacogenetic Decision Algorithm

Saeed K Alzghari et al. Cureus. .

Abstract

Personalized medicine is playing an ever-increasing role in patient care. Over the past decade, awareness of the role of pharmacogenetics and its benefits is leading to its growing acceptance among providers. Though providers are using pharmacogenetics in practice, the decision-making process of when to use this tool can be ambiguous. Herein, we propose an algorithm to help guide providers on when to use pharmacogenetics for patient care.

Keywords: biotechnology; cytochrome p450; pharmacodynamics; pharmacogenetics; pharmacokinetics.

PubMed Disclaimer

Conflict of interest statement

The authors have declared financial relationships, which are detailed in the next section.

Figures

Figure 1
Figure 1. Pharmacogenetic decision algorithm
See this image and copyright information in PMC

References

    1. Personalized medicine and the practice of medicine in the 21st century. Issa AM. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323540/ Mcgill J Med. 2007;10:53–57. - PMC - PubMed
    1. Pharmacogenomics in clinical practice: reality and expectations. Ventola CL. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171815/ P T. 2011;36:412–450. - PMC - PubMed
    1. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. Mega JL, Simon T, Collet JP, et al. JAMA. 2010;304:1821–1830. - PMC - PubMed
    1. Pharmacogenetics of antidepressant response. Porcelli S, Drago A, Fabbri C, Gibiino S, Calati R, Serretti A. J Psychiatry Neurosci. 2011;36:87–113. - PMC - PubMed
    1. Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. Zhang JP, Malhotra AK. Expert Opin Drug Metab Toxicol. 2011;7:9–37. - PMC - PubMed

Publication types

LinkOut - more resources